OncoCyte Corp
NASDAQ:OCX

Watchlist Manager
OncoCyte Corp Logo
OncoCyte Corp
NASDAQ:OCX
Watchlist
Price: 3.16 USD -1.25% Market Closed
Market Cap: 90.4m USD

Wall Street
Price Targets

OCX Price Targets Summary
OncoCyte Corp

There are no price targets for OCX.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
OncoCyte Corp Competitors:
Price Targets
TRDA
Entrada Therapeutics Inc
232% Upside
ACHV
Achieve Life Sciences Inc
448% Upside
ATYR
aTyr Pharma Inc
282% Upside
NTLA
Intellia Therapeutics Inc
196% Upside
PYC
PYC Therapeutics Ltd
169% Upside
ADOC
Adocia SA
34% Upside
ORKA
Oruka Therapeutics Inc
165% Upside
OSTX
OS Therapies Inc
474% Upside

Revenue
Forecast

Revenue Estimate
OncoCyte Corp

The compound annual growth rate of OncoCyte Corp's revenue for the next 3 years is 92%.

N/A
Past Growth
92%
Estimated Growth
Estimates Accuracy
-46%
Average Miss

Operating Income
Forecast

Operating Income Estimate
OncoCyte Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
OncoCyte Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-89%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is OCX's stock price target?
Not Available

OCX doesn't have any price targets made by Wall Street professionals.

What is OncoCyte Corp's Revenue forecast?
Projected CAGR
92%

The compound annual growth rate of OncoCyte Corp's revenue for the next 3 years is 92%.

Back to Top